The Roslin Institute
Roslin logo

Funding supports research towards veterinary vaccines

Award enables continuity of efforts for international hub for livestock and zoonotic vaccinology research.

A Roslin-led initiative to advance vaccine development for livestock and zoonotic diseases is being supported with a funding award.

The International Veterinary Vaccinology Network (IVVN), based at the Roslin Institute in partnership with the Pirbright Institute, has received a £1.2 million grant from the Medical Research Council (MRC) to continue its activities to support global veterinary vaccinology research.  

The funding is sourced from the UK Government's International Science Partnerships Fund (ISPF).  

International network

IVVN has developed into a global community comprising more than 1,900 scientists and industry partners from 93 countries since its formation in 2007.

The initiative facilitates networking, providing funding for veterinary vaccine research, supporting early career researchers and being a central hub for the international veterinary vaccinology community. 

IVVN is one of five Global Vaccine Networks that collectively form a collaborative platform for researchers from the UK and around the world, particularly from low- and middle-income countries, to share knowledge and expertise, contributing to the development of new or enhanced vaccines.  

Recognising their impact, UK Research and Innovation (UKRI) has allocated £6.3 million to support these networks, for an additional two years.  

Further investment

The funding ensures the continuity of IVVN's activities and strengthens its commitment to fostering collaboration between human and veterinary vaccine research communities.

It will enable IVVN to provide funding for scientific collaboration, offer valuable training opportunities, and continue inspiring and engaging the next generation of scientists.    

We are delighted to have been awarded funding to continue our activities to support veterinary vaccinologists across the world.

With this funding, we will continue efforts to bring the human and veterinary vaccine research communities together, support scientific collaboration by providing pump-priming funding, provide training for early career researchers and expand our schools outreach programme to inspire the next generation of scientists.

­­­Dr Timothy ConnelleyNetwork Director of IVVN, Roslin Institute

The UK’s research and innovation system thrives through international partnerships, so I’m delighted these networks are able to continue their incredible work tackling infectious diseases that pose threats to people, livestock, crops and natural resources.

Investing in collaborations like these will better prepare us for future disease epidemics and to more effectively tackle the slow-moving pandemic of antimicrobial resistance. These global networks are integral to ensuring the UK harnesses the extraordinary potential of research and innovation to enrich and improve the lives of people living in the UK and around the world.

Dr Mark PalmerDirector of International Strategy, Medical Research Council

 ** The Roslin Institute receives strategic investment funding from the Biotechnology and Biological Sciences Research Council and it is part of the University of Edinburgh’s Royal (Dick) School of Veterinary Studies. **

Related links


Image credit: Chris Roberts/Unsplash